DekaBank Deutsche Girozentrale
NGNE icon

DekaBank Deutsche Girozentrale’s Neurogene NGNE Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-700
Closed -$129K – 1407
2021
Q2 		$129K Hold
700
– – ﹤0.01% 1301
2021
Q1 		$165K Hold
700
– – ﹤0.01% 1218
2020
Q4 		$198K Buy
+700
New +$171K ﹤0.01% 1184

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

DekaBank Deutsche Girozentrale's NGNE Position: Q3 2021 in Review

DekaBank Deutsche Girozentrale sold out of Neurogene (NGNE) in Q3 2021, closing a stake of 700 shares — an estimated $129K sold.

DekaBank Deutsche Girozentrale first reported a position in NGNE in Q4 2020 and held it in 3 quarters. The position peaked at $198K in Q4 2020. 85 funds tracked by Wall St. Rank hold NGNE as of Q3 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Neurogene position as of Q3 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 700 Neurogene shares in Q3 2021, an estimated $129K.
  • DekaBank Deutsche Girozentrale first reported a position in Neurogene in Q4 2020 and held it in 3 quarters.
  • DekaBank Deutsche Girozentrale's Neurogene position peaked at $198K in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Neurogene as of Q3 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2021, filed 22 Oct 2021.